Announced Sat, 30 May · 17:59 IST

Please find enclosed Audited financial results for March 2026

Revenue DeclinePat NegativeResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.3%1-day move
₹15.15
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3-2.8+1.7-3.2-9.6-8.3-1.1-1.9
Up moveDown movePending
AI summary

Tejnaksh Healthcare reported audited results for FY26 with an unmodified opinion from auditors Maheshwari & Co. On a standalone basis, revenue from operations declined 18.4% to Rs 717.72 lakh from Rs 879.31 lakh in FY25. Profit after tax fell significantly by 47.4% to Rs 137.98 lakh from Rs 262.15 lakh. EPS dropped to Rs 0.68 from Rs 1.29. On the consolidated basis, profit before tax was Rs 164.62 lakh compared to Rs 319.14 lakh in the prior year. The company has become debt-free, with borrowings reduced to zero from Rs 105.27 lakh previously. Operating cash flow remained positive at Rs 171.58 lakh. The auditor confirmed an unmodified (clean) opinion, and there were no qualifications or emphasis of matter paragraphs in the report.

Likely market impact

The sharp decline in both revenue and profitability is a concern for shareholders. Despite becoming debt-free, the company is earning significantly less than the previous year, which may pressure the stock price in the near term.